Hansen P V, Trykker H, Helkjoer P E, Andersen J
Department of Experimental Clinical Oncology, Danish Cancer Society, Arhus, Denmark.
J Natl Cancer Inst. 1989 Aug 16;81(16):1246-50. doi: 10.1093/jnci/81.16.1246.
Gonadal function was evaluated in 25 patients with metastatic testicular cancer who were treated with orchiectomy plus chemotherapy with cisplatin, vinblastine, and bleomycin (PVB) and in 21 patients with clinical stage I disease who were treated only with orchiectomy and then kept under surveillance. Four years after PVB treatment, none of the patients were azoospermic; after 5 years, the total sperm counts in 46% of the patients had reached their pretreatment levels. In the group under surveillance, sperm counts below the reference level persisted or developed in 55% of the patients. Sperm production was similar in the two groups of patients 1.5 years after treatment and beyond. We conclude that spermatogenesis is not restored in all patients treated with PVB because of both preexisting germ cell defects and treatment toxicity.
对25例转移性睾丸癌患者的性腺功能进行了评估,这些患者接受了睾丸切除术加顺铂、长春花碱和博来霉素(PVB)化疗;对21例临床I期疾病患者进行了评估,这些患者仅接受了睾丸切除术,然后进行监测。PVB治疗4年后,无一例患者无精子症;5年后,46%的患者精子总数达到治疗前水平。在监测组中,55%的患者精子计数持续低于参考水平或出现下降。两组患者治疗1.5年后及之后的精子生成情况相似。我们得出结论,由于存在预先存在的生殖细胞缺陷和治疗毒性,接受PVB治疗的所有患者的精子发生并未恢复。